Emerging Immunotherapies for Parkinson Disease

Symptomatic treatment options for Parkinson disease have steadily improved, and individualized therapeutic approaches are becoming established for every stage of the disease. However, disease-modifying therapy with a causal approach is still unavailable. The central causative role of alpha-synuclein...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurol Ther
Asıl Yazarlar: Zella, Samis M. A., Metzdorf, Judith, Ciftci, Emine, Ostendorf, Friederike, Muhlack, Siegfried, Gold, Ralf, Tönges, Lars
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Healthcare 2018
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534677/
https://ncbi.nlm.nih.gov/pubmed/30539376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-018-0122-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller